Detalhe da pesquisa
1.
BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
J Virol
; 96(12): e0052822, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35604219
2.
Novel approaches for bioinformatic analysis of salivary RNA sequencing data for development.
Bioinformatics
; 34(1): 1-8, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961734
3.
Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
Virol J
; 16(1): 156, 2019 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842907
4.
Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
J Virol
; 91(16)2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566375
5.
Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing.
Clin Chem
; 64(7): 1085-1095, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685897
6.
Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
Clin Chem
; 64(10): 1513-1521, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097497
7.
Robust Real-Time Reverse Transcription-PCR for Detection of Foot-and-Mouth Disease Virus Neutralizing Carryover Contamination.
J Clin Microbiol
; 54(1): 216-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560537
8.
Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
J Virol
; 89(16): 8267-79, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041279
9.
Inactivation of foot-and-mouth disease virus by citric acid and sodium carbonate with deicers.
Appl Environ Microbiol
; 81(21): 7610-4, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319879
10.
Bovine Genome-wide Association Study for Genetic Elements to Resist the Infection of Foot-and-mouth Disease in the Field.
Asian-Australas J Anim Sci
; 28(2): 166-70, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557811
11.
Reemergence of foot-and-mouth disease, South Korea, 2000-2011.
Emerg Infect Dis
; 20(12): 2158-61, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25417549
12.
Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia.
Vaccines (Basel)
; 12(1)2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250877
13.
Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation.
Front Cell Infect Microbiol
; 14: 1331779, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510965
14.
Porcine interferon-α linked to the porcine IgG-Fc induces prolonged and broad-spectrum antiviral effects against foot-and-mouth disease virus.
Antiviral Res
; 223: 105836, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360296
15.
D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant.
Front Immunol
; 15: 1330677, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433834
16.
Control of foot-and-mouth disease during 2010-2011 epidemic, South Korea.
Emerg Infect Dis
; 19(4): 655-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23632094
17.
Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon.
Front Microbiol
; 14: 1121830, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37250022
18.
Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O.
Vaccines (Basel)
; 11(2)2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851149
19.
Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease.
Front Microbiol
; 14: 1289065, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029108
20.
Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.
Vaccines (Basel)
; 11(9)2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766163